Comparison of the effectiveness of the three treatment methodes; transecutaneous nerve stimulation by constant parameters, transecutaneous nerve stimulation by variasble parameters and treatment by Solifenaci

Not Applicable

Recruiting

• Conditions: Women's urgent incontinence.; Urge incontinence; N39.41

• Registration Number: IRCT20190202042581N2
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 16

Inclusion Criteria

Postmenopausal women
Age over 50 years
Urine excretion at least 8 times a day, based on history or voiding diary
ore than once, the episode was an urgency with or without discretion

Exclusion Criteria

Sensitivity to sulfenacin or its elements
Urinary retention
Gastric retention
Neuropathy
Uncontrolled narrow glaucoma angle

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of incontinence. Timepoint: At the beginning of the study and 6 weeks after starting treatment. Method of measurement: OABS questionnaire.;Quality of life. Timepoint: At the beginning of the study and 6 weeks after starting treatment. Method of measurement: Quality of Life questionnaire.

Secondary Outcome Measures

Name	Time	Method
The frequency of urinary leakage. Timepoint: At the beginning of the study and 6 weeks after starting treatment. Method of measurement: Patient report.;Frequent feelings of urgency. Timepoint: At the beginning of the study and 6 weeks after starting treatment. Method of measurement: Patient report.